MALVERN, PA — YPrime has announced that Dr. Karl McEvoy, Vice President of eCOA and Patient Technologies, has been appointed Industry Co-Director of the Critical Path Institute’s eCOA Consortium for 2025.
Dr. McEvoy brings over a decade of experience in eCOA and clinical technology, with a focus on enhancing patient-centered data collection and improving clinical trial processes. His new role will involve collaborating with industry leaders to establish standards, conduct research, and develop best practices for the electronic collection of patient-reported and digital health technologies data in clinical trials.
“It’s a privilege to step into this position, and I take seriously our responsibility to both clinical trial participants and site personnel,” said McEvoy. “I look forward to working alongside such respected colleagues to shape the future of eCOA, as we remain committed to raising the bar for clinical outcomes through innovation and user-centric solutions.”
The eCOA Consortium, established in 2011, is dedicated to providing scientific leadership and best-practice guidance around electronic data capture technologies used in clinical research.
“Karl’s leadership exemplifies YPrime’s dedication to designing cutting-edge technologies that address the needs of trial participants, site teams, and sponsors,” remarked Mark Maietta, President of YPrime. “His role as Industry Co-Director underscores our deep expertise and unwavering commitment to delivering world-class eCOA solutions that drive patient engagement and trial success.”
Dr. McEvoy’s appointment highlights YPrime’s ongoing leadership in advancing clinical trial technologies and fostering patient-centric innovations.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.